Beneficial effect of acitretin in Chanarin-Dorfman syndrome

Clin Exp Dermatol. 2012 Jan;37(1):31-3. doi: 10.1111/j.1365-2230.2011.04164.x. Epub 2011 Oct 10.

Abstract

Chanarin-Dorfman syndrome (CDS) is an autosomal recessive metabolic disorder characterized by congenital ichthyosis and visceral complications due to accumulation of neutral lipids. CDS is caused by mutations in the ABHD5 (previously termed CGI-58) gene. In the present study, we assessed a young child presenting with ichthyosis and hepatomegaly, suggesting a diagnosis of CDS. We identified an intronic mutation, c.960 + 5G>A, which was found to result in skipping of exon 6. Abnormal results on liver function tests led us to treat the child with acitretin, which resulted in satisfactory clinical and laboratory responses. The present case illustrates the beneficial effect of acitretin treatment in CDS even in the presence of compromised liver function.

Publication types

  • Case Reports

MeSH terms

  • 1-Acylglycerol-3-Phosphate O-Acyltransferase / genetics
  • Acitretin / therapeutic use*
  • Child, Preschool
  • Female
  • Humans
  • Ichthyosiform Erythroderma, Congenital / drug therapy*
  • Ichthyosiform Erythroderma, Congenital / genetics
  • Keratolytic Agents / therapeutic use*
  • Lipid Metabolism, Inborn Errors / drug therapy*
  • Lipid Metabolism, Inborn Errors / genetics
  • Muscular Diseases / drug therapy*
  • Muscular Diseases / genetics
  • Treatment Outcome

Substances

  • Keratolytic Agents
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase
  • ABHD5 protein, human
  • Acitretin

Supplementary concepts

  • Chanarin-Dorfman Syndrome